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Summary 
Targeted inactivation of genes involved in murine cardiovascular development frequently leads to 
abnormalities in blood flow.  Since blood fluid dynamics play a crucial role in shaping vessel 
morphology, the presence of flow defects generally prohibits the precise assignment of the role of 
the mutated gene product in the vasculature.  In this study, we show how to distinguish between 
genetic defects caused by targeted inactivation of the Neuropilin-1 (Nrp-1) receptor, and 
hemodynamic defects occurring in homozygous knockout embryos. Our analysis of a nrp-1 null 
allele bred onto a C57BL/6 background shows that vessel remodeling defects occur 
concomitantly with the onset of blood flow and cause death of homozygous mutants at E10.5. 
Using mouse embryo culture, we establish that hemodynamic defects are already present at E8.5 
and continuous circulation is never established in homozygous mutants.  The geometry of yolk 
sac blood vessels is altered and remodeling into yolk sac arteries and veins does not occur. To 
separate flow-induced deficiencies from those caused by the nrp-1 mutation, we arrested blood 
flow in cultured wild-type and mutant embryos and followed their vascular development.  We 
find that loss of Nrp-1 function rather than flow induces the altered geometry of the capillary 
plexus.  Endothelial cell migration, but not replication is altered in nrp-1 mutants. Gene 
expression analysis of endothelial cells isolated from freshly dissected wild-type and mutants and 
after culture in no-flow conditions showed down-regulation of the arterial marker genes 
connexin-40 and ephrinB2 related to the loss of nrp-1 function.  This method allows genetic 
defects caused by loss-of-function of a gene important for cardiovascular development to be 
isolated even in the presence of hemodynamic defects. 
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Introduction 
The cardiovascular system is one of the few organ systems that must be functional as it develops.  
In mice, the embryonic heart forms as a linear tube at embryonic day 8 (E8.0) that must beat and 
supply blood flow before it has undergone looping, trabeculation or compartmentalization.  The 
early blood vessels form as a capillary plexus in an extraembryonic membrane called the yolk 
sac.  Prior to the onset of heart-beat, this plexus is devoid of visible arteries or veins and the 
vessels lack peripheral cell coverage.  When blood first flows through the capillary plexus, the 
network is rapidly remodeled into a functional circulatory system composed of arteries, veins and 
capillaries.  Structure and function develop in a coordinated manner and proper blood flow is 
required for normal cardiovascular development (Chapman, 1918; le Noble et al., 2004; Lucitti et 
al., 2007).  If blood flow is stopped or is sufficiently abnormal, the blood vessels remain as a 
capillary plexus and do not undergo subsequent aspects of cardiovascular development.  
Therefore the role of signaling molecules in the developing cardiovascular system is often 
obscured by the varied inputs of an organ system that has already begun to function.   
 
In many cases, null mutations for genes required for proper vascular development also perturb 
proper blood flow.  Genes that are expressed in the endothelium are most often also expressed in 
the endocardial lining of the heart, which could affect function.  Irregularities in vascular 
geometry, such as occlusions or shunts, can also cause abnormal flow (Jones et al., 2004).  
Therefore, if a gene is important enough to visibly perturb cardiovascular structures, it will often 
perturb cardiovascular function as well.  Over 50 genes have been published that cause a failure 
of yolk sac remodeling (personal communication with Mary Dickinson).  Though improper blood 
flow can cause this phenotype, early circulatory function has been investigated in only a minority 
of these embryos.  Vascular abnormalities present in the N-cadherin null mouse can be rescued by 
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restoring normal blood flow using cardiac-specific expression of either N- or E-cadherin (Luo et 
al., 2001), indicating that the observed vascular abnormalities are secondary to the abnormal 
blood flow.  Abnormal or absent blood flow has been shown to cause failure to remodel in 
embryos (Lucitti et al., 2007), more cuboidal endothelial cell shape (May et al., 2004), vessel 
regression (Clark, 1918; Meeson et al., 1996; Thoma, 1893), abnormalities in peripheral cell 
recruitment (Grazioli et al., 2006) and changes in vessel diameter (Thoma, 1893).  Proper 
vascular development requires a complex interaction of both genetic and physical signals, where 
one cannot develop normally without the other.  It is therefore essential to separate when these 
events occur because of the mutation of interest and when they are induced by abnormal blood 
flow. 
 
The Neuropilin-1 (Nrp-1) receptor was originally identified as a receptor for the axon guidance 
molecule Semaphorin3A and is implicated in the development of the nervous system (He and 
Tessier-Lavigne, 1997; Kolodkin et al., 1997).  Nrp-1 is also an isoform-specific receptor for 
VEGF165 (Soker et al., 1998) and plays an important role in the cardiovascular system, as deletion 
of the nrp-1 gene leads to embryonic lethality due to cardiovascular malformations.  Lethality 
occurs between E10.5 and E13.5, depending on the genetic background (Kitsukawa et al., 1997).  
On a CD-1 background, embryos lacking nrp-1 exhibit defects in the formation of the heart 
outflow tract and aortic arches (Kawasaki et al., 1999).  In addition, they exhibit abnormal 
vascular network formation in the yolk sac (Kawasaki et al., 1999) and abnormal sprouting of 
hindbrain vessels (Gerhardt et al., 2004).  Furthermore, in endothelial-specific nrp-1 knockouts, 
certain arterial markers are missing from arterioles and arteries (Mukouyama et al., 2005).  The 
presence of both cardiac and vascular defects indicated that nrp-1 null embryos could present 
abnormal blood flow patterns and that aspects of their phenotype could be induced by improper 
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flow rather than by loss of function of the receptor.  We therefore decided to examine flow 
patterns in relation to vascular defects in these embryos. 
 
We investigate here the cardiovascular phenotype of a nrp-1 mutant allele (Gu et al., 2003) bred 
on a C57BL/6 background. Nrp-1-/- embryos die at E10.5 with severe vascular abnormalities that 
are accompanied by abnormal flow patterns.  In order to separate flow-induced defects from 
defects induced by the nrp-1 mutation, we compared wild-type and mutant embryos in the 
absence of flow.  We find that the yolk sac vascular defects are not related to the flow defect but 
due to loss of Nrp-1 function.  Function-blocking anti-Nrp-1 antibodies (Pan et al., 2007a) 
injected into wild-type embryos can reproduce the yolk sac vessel defects observed in nrp-1 
mutants in a normal flow environment.  By identifying an aspect of the mutant phenotype that is 
not dependent on flow, we are then able to investigate the genetic causes of this defect.  We find 
that nrp-1-/- endothelial cells exhibit normal replication, but altered migration and defective 
arterial differentiation.   
 
Materials And Methods 
Mice 
Nrp-1 mutant mice on a C57BL/6 background were generated as described (Gu et al., 2003).  
Briefly, a conditional targeted allele contained two loxP sites flanking exon 2 of the nrp-1 gene 
was created. Npn-1 null mice were obtained by crossing mice harboring this conditional allele 
with mice expressing Cre recombinase in the germline. The colony was maintained by breeding 
heterozygous male mice with wild-type C57BL/6 (Charles River Laboratories). Genotyping was 
performed using Ready-to-go PCR beads (Amersham Pharmacia Biotech, No. 27955801) with 
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forward primer GCC AAT CAA AGT CCT GGA AGA CAG and reverse primer CTG CAG 
ATC ATG TAT ACT GGT GAC.  
 
Immunohistochemistry and In Situ Hybridization 
For whole mount stainings, embryos were fixed in Dent’s fixation (4 parts MeOH: 1 part DMSO) 
overnight at 4°C.  Embryos were progressively rehydrated and blocked twice for one hour in 
TNB (Roche No. 11096176001).  Embryos were incubated overnight at 4°C with primary 
antibodies (1:100) in TNB (biotinylated α-PECAM-1, BD Bioscience No. 553371; rabbit α-
human Collagen IV, Serotec No. 2150-0140; phospho-histone 3, Abcam No. ab5176-100).  
Embryos were washed, re-blocked and incubated overnight with fluorescent streptavidin or 
fluorescent secondary antibodies (1:400) at 4°C.  
 
For sections, embryos were dissected and fixed in 4% PFA overnight at 4°C.  Embryos were 
washed in 70% ethanol, stained with eosin, dehydrated and embedded in paraffin.  
Immunohistochemistry was performed using the Tyramide Signal Amplification system (TSATM, 
NENTM Life Science Products, Boston, MA).  
 
In situ hybridization has been described previously (Moyon et al., 2001a) with probes for dll4 
(Suchting et al., 2007), nrp-1 (Yuan et al., 2002), efnb2 (Moyon et al., 2001b) and cx40 
(Mukouyama et al., 2005). 
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Quantitation of Vascular Phenotype 
After PECAM-1 stainings, yolk sacs were mounted and imaged on a fluorescent microscope 
(magnification 20x).  Using ImageJ, images were filtered and converted to binary images.  Total 
vessel area was assessed by counting the number of white vs black pixels in the binary images.  
Network morphology was quantified using the Biologic Analyzer, a software program developed 
by Nicolas Elie (Centre de Morphologie Mathematiques-ARMINES, France).  This program 
extracts the skeleton of the vascular network from binary images (Beucher, 1990; Coster and 
Chermant, 1985) and points where the skeleton lines intersect are counted as branchpoints 
(Ablameyko and Pridmore, 2000) (Suppl. Fig. 1).  Segment length was assessed by dividing the 
total length of all skeleton lines by the number of intersections.  Vessel diameter was assessed 
indirectly, by measuring the average area of an avascular space (hole) between vessels. Four to 
five images per yolk sac and a minimum of three yolk sacs per group were analyzed. 
 
Flow Assessment and Creation of No Flow Embryos 
Breeding pairs of mice were mated overnight and the presence of a vaginal plug denoted E0.5.  
Embryos were collected at E8.5 and cultured as described (Jones et al., 2002) except that roller 
culture rather than static culture was used.  For analysis of flow, embryos were collected at 5 
somites and cultured for 6 or 24 hours.  The yolk sac was observed under white light (10x 
magnification), focusing especially on the outlet of the dorsal aorta where the fastest and most 
visible flow is located.  Embryos were time-lapsed by placing them on a heated stage after culture 
and images were taken with white light at a rate of approximately 2 Hz.  
 
To create no flow embryos, 3-4 somite stage embryos were held with No. 5 watchmaker forceps 
and the yolk sac and inlets to the heart were snipped on both sides of the heart using No. 55 
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watchmaker forceps. The embryos were then cultured for 24 hours.  Most embryos recovered 
from the injury and had normally inflated yolk sacs (not shown) though the inlet to the heart was 
deformed and embryos never turned. 1-2 embryos per litter had deflated yolk sacs or still had 
blood circulation and were discarded. 
 
Embryo Injections And Migration Assay 
Injections were performed using a pulled quartz needle filled with either 70,000 MW Texas Red 
dextran (Molecular Probes, No. D-1828) for angiograms, or protein solutions (Nrp-1 blocking 
antibodies, Pan et al., 2007a, all others from R&D systems) for Nrp-1 blocking experiments.  For 
protein solutions, a small quantity of 70,000 MW Texas Red dextran was added to visualize 
injection.  A picospritzer II (General Valve Corp.) was used to inject, the volume of the injections 
was set by varying the pressure until the desired amount of dye was expunged.  The needle was 
inserted into the heart of the embryos (10 somites for angiograms, 4 somites for protein 
solutions), through the yolk sac.  Long thin quartz needles were used to prevent damage to the 
yolk sac.  Several pulses of solution were injected into the beating heart and dye could be 
visualized during injection entering the yolk sac and filling the vessels.  This ensured accurate 
and specific dosing to only the cardiovascular system.  Approximate dosing of protein solutions 
was calculated using an order of magnitude estimation. An embryo’s dimensions are about 1mm 
x 100 μm x 100 μm at this stage and the density of an embryo is approximately equal to that of 
water.  With approximately 10 nL of protein solution injected (4.4 mg/mL and 7.6 mg/mL for α-
Nrp-1A and α-Nrp-1B respectively), the dose is an order of magnitude of 103-104 mg of 
protein/kg of embryo.   
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In the case of the migration assay, CM-DiI (Invitrogen, no. C7001) dye was injected focally onto 
the yolk sac.  Embryos (n=23 wild-type or heterozygotes, 5 nrp-1-/-) were cultured for 24 hours 
and then photographed using bright-field and fluorescent light on a Leica fluorescent dissecting 
microscope.  Using photoshop, the distance from the center of the injection site to the most 
distant fluorescent endothelial cell was measured. 
 
Isolation of Embryonic Endothelial Cells and Quantitative RT-PCR  
Embryos were collected at E9.5 or after 24 hours of culture starting at E8.5.  Two to three 
embryos that appeared to be of the same genotype were pooled and digested with collagenase for 
40 minutes.  Endothelial cells were then separated using Dynabeads (Invitrogen No. 110-35) 
coated with PECAM-1 antibody (BD Bioscience No. 553369), non-endothelial cells were 
collected for genotyping. Endothelial cell RNA was extracted using an RNeasy micro kit (Qiagen 
No. 74004).  Retrotranscription was performed using MMLV reverse transcriptase and Oligo dT 
primers.  SYBR green PCR mix (Qiagen No. 204145) and a Biorad iCycler were used to 
quantitate gene expression in these samples.  All primers were QuantiTect Primer Assays 
(Qiagen).  A total of 6 sets of 2-3 embryos with the correct genotype was used quantitate gene 
expression in each group. 
 
Results 
Cardiovascular Phenotype of the nrp-1-/- Embryos 
Neuropilin-1 (nrp-1) knock-out mice were generated by crossing mice harboring a conditional 
nrp-1 allele with mice expressing Cre recombinase in germ cells, as described (Gu et al., 2003). 
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Chimeras were backcrossed on a pure C57BL/6 background for > 7 generations.  We examined 
the cardiovascular phenotype between E8.0 (4-6 somites) and E11.5.  
 
In wild-type embryos, the earliest vessels form in the yolk sac, an extra-embryonic tissue that 
surrounds the developing embryo.  This de novo vessel formation occurs between E8.0 and E8.5 
and is known as vasculogenesis.  As these early vessels connect to the embryonic heart and the 
heart begins to beat, the yolk sac vasculature is remodeled into a more hierarchical structure 
composed of arteries, capillaries and veins that can be visualized at E9.5 in freshly dissected 
embryos and by staining with the pan-endothelial marker PECAM-1 (Fig. 1A, B).  Nrp-1 null 
embryos fail to undergo vascular remodeling and exhibit poorly branched, enlarged vessels 
throughout the yolk sac at E9.5 (Fig. 1E, F).  The caliber of yolk sac vessels in nrp-1-/- embryos is 
similar to that of large arteries of the yolk sac in the wild-type embryos (Fig. 1B, F).  As well, 
large avascular spaces are observed between the mutant vessels (Fig. 1E, F).  
 
De novo formation of blood vessels in nrp-1 null embryos appeared identical to wild-type until 
E8.5 (data not shown), suggesting a possible requirement of nrp-1 during the process of vessel 
remodeling but not vessel formation.  To determine when the mutant phenotype became apparent, 
we injected fluorescently tagged dextran into the heart of normal (Fig. 1C) and mutant embryos 
(Fig. 1G) at 10 somites (E8.75), just after the normal onset of blood flow.  The dextran highlights 
the vasculature of the heart, yolk sac and dorsal aortae in both wild-type and knockout embryos, 
indicating that lumenized vessels are present in nrp-1-/- embryos.  However, the large dilated 
vessels and avascular spaces were already apparent in the mutant yolk sacs at this stage, 
indicating that the phenotype appears concomitantly with the onset of blood flow.  
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To quantitate the difference in the vascular phenotypes, we performed morphometric analysis 
(Suppl. Fig. 1) and measured total vessel coverage, the number of vessel branch points, segment 
length and avascular spaces between capillaries on PECAM stained yolk sacs of wild-type and 
mutants (Fig. 1D, H).  Before the onset of flow (E8.0, 4-6 somites), there was no statistically 
significant difference in overall vessel coverage, number of branchpoints or segment length 
between embryos of different genotypes (Fig. 1I-K).  Overall vessel coverage remained similar 
between wild type and nrp-1 mutants at subsequent developmental stages (data not shown).  
However, the number of vessel branchpoints decreased in the nrp-1 mutant yolk sacs just after the 
onset of blood flow at 7-10 somites (E8.5) and at 20-25 somites (E9.5) (Fig. 1I). If the total vessel 
area is constant, and the number of vessel branchpoints is reduced, one expects that the length of 
individual vessel segments increases, which is what we observed in the nrp-1 mutant compared to 
wild-type (Fig 1J).  The average size of avascular areas (holes) separating capillaries increased in 
nrp-1-/- mutants compared to wild-type both at 7-10 somites and at 20-25 somites (Fig. 1K).  With 
constant vessel area and increased space between vessels, it follows that the individual segments 
must be thicker.  Taken together, this quantification revealed that nrp-1 null yolk sac vessels show 
normal overall vessel coverage, but altered vascular geometry, with less branched, thicker vessels 
separated by large avascular spaces and that these defects appear concomitantly with the onset of 
blood flow.  
 
Examination of the embryo proper between E8.5 and E9.5 showed that somite addition in nrp-1-/- 
embryos occurred at normal rate until E9.5 (23 to 25 somites), but ceased afterwards.  A 
developmental delay of nrp-1-/- compared to wild-type or heterozygous littermates became 
apparent at E9.5.  Live knockout embryos could be recovered until E10.5, but were severely 
growth retarded at this stage (data not shown).  Taken together, we observe that nrp-1-/- embryos 
on the C57BL/6 background die at E10.5, consistent with previous reports of a different nrp-1 
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mutant allele bred on this background (Kitsukawa et al., 1997), and exhibit vessel remodeling 
defects that appear concomitant with the onset of blood flow.  
 
Nrp-1-/- Embryos Exhibit Abnormal Blood Flow 
Since proper blood flow is required for remodeling to occur (le Noble et al., 2004; Lucitti et al., 
2007), we next investigated whether normal blood flow was present in nrp-1-/- embryos.  In wild 
type embryos, the heart starts beating at the 3-somite-stage, initiates a period of plasma flow 
through the primitive vascular plexus from 3 somites until 5-6 somites, which is followed by the 
gradual entry of erythroblasts into circulation.  Continuous circulation, where vessels are 
consistently filled with flowing erythroblasts, is established by approximately 8 somites (Lucitti 
et al., 2007).  We investigated whether erythroblasts circulated in nrp-1-/- mutants by placing 
embryos at E8.5 (5-7 somites) into culture for 6 or 24 hours, as previously described (Jones et al., 
2004).  The embryos were removed from culture and observed under white light for circulating 
erythroblasts (Table I).  Using this method, we saw erythroblasts circulating in 100% of E8.5 
wild-type embryos (n=12, Suppl. Movie1) and 100% of E9.5 wild-type embryos (n=13).  In 
contrast, normal circulation was not observed at either stage in embryos lacking nrp-1.  In E8.5 
mutant embryos, erythroblasts could only be seen oscillating in place (Table I, Suppl. Movie 2) 
and continuous movement of erythroblasts through the early vascular plexus was never observed.  
By E9.5, no erythroblast motion was observed in the mutant embryos (n=4) and circulation had 
completely arrested.  Thus, nrp-1 homozygous mutants can initiate heart contraction and plasma 
flow (Fig. 1G), but fail to initiate erythroblast circulation. 
 
To investigate possible causes of the defective blood flow, we sectioned and stained wild-type 
and mutant embryos at E8.5 and E9.5 (Fig. 2).  Nrp-1 expression in arteries of the E8.5 (10 
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somite stage) embryo and yolk sac vessels (Fig. 2A), detected by in situ hybridization, provided a 
possible causative explanation for the vascular remodeling defect.  In addition, nrp-1 stained the 
atrial compartment of the heart (Fig. 2A).  By RT-PCR, we could detect nrp-1 expression in the 
heart as early as 4 somites (n = 4), and this expression was sustained at 7 somites (n=4) and 10 
somites (n=4).  
Lack of cardiac nrp-1 expression could cause the observed blood flow defects, as oscillatory flow 
has previously been seen in embryos that specifically lack the atrial component of heart 
contractions (Lucitti et al., 2007).  The heart of nrp-1 null embryos underwent proper looping at 
E8.5, however the pericardial sac of the mutant embryos was consistently enlarged by E10.5 
(n=7) and no trabeculation was observed from E9.5 onwards.  At E8.5, the endocardial lining 
stained positively for PECAM-1 and was present in both wild-type and mutant embryos (data not 
shown).  The size of the heart also appeared to be normal.  Therefore, the heart appeared 
morphologically normal at 10 somites when flow problems could already be observed. To 
determine if heart function was normal in the nrp-1 null embryos, we placed embryos at the 6 
somite stage into culture for 6 hours and observed the form of the heart contraction.  Heart 
contractions initiate at the base of the heart and move anteriorly in both wild-type and nrp-1 
knockout embryos (n=8 for wt and n=3 for mutant).  Heart rate also did not differ significantly 
between wild-type and mutant (51± 4.5 bpm and 40± 5.7 bpm, respectively, Supplemental 
Movies 1, 2).  We therefore conclude that heart function is also grossly normal in the mutant 
embryos, although more subtle defects could not be detected with this method.  
 
Since cardiac function appeared grossly normal, we next looked at whether the vasculature of the 
embryo proper had formed normally.  PECAM-1 staining at E8.5 showed that both dorsal aortae 
were present in wild type (Fig. 2B) and mutant embryos (Fig. 2D).  The diameter of these vessels 
appeared normal throughout the embryo, but Nrp-1-/- vessels were often collapsed, perhaps 
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impeding blood flow and circulation, although the dextran injections showed that vessels were 
lumenized at this stage (Fig. 1G).  At E9.5, Collagen IV staining on sections from wild-type 
embryos revealed two dorsal aortae on either side of the neural tube (Fig. 2C).  One or both of 
these vessels, at the level of the heart, were missing in nrp-1 mutant embryos (Fig. 2E, G, Fig. 
4B), though they were generally still present at the caudal end of the embryo.  E9.5 nrp-1 mutant 
embryos also showed delayed vessel sprouting into the intersomitic regions when compared to 
wild-type (Fig. 2F,G), though sprouts that progressed far enough interconnected as in wild-type.  
The cephalic vascular plexus developed in nrp-1-/- embryos, although the vessels were thinner and 
sparser than in normal embryos and did not appear to be lumenized (Fig. 2H,I).  Smooth muscle 
cells, visualized with α-SMA staining, surrounded the major vessels of the embryo in wild-type 
embryos, but were not present either in the head or trunk region of homozygous mutant embryos 
(data not shown).  
 
Separating the Role of Blood Flow From Nrp-1 Function 
As the histological and functional analysis of the cardiovascular system in nrp-1 null embryos did 
not reveal a major defect in the mutant heart or vessels of the embryo proper, the yolk sac 
vascular phenotype in nrp-1-/- mice could be due to defective flow causing defective vessel 
remodeling or vice versa.  We therefore sought to differentiate primary effects caused by lack of 
nrp-1 from secondary defects caused by abnormal flow. 
 
We suspected a direct role of Nrp-1 signaling during the formation of yolk sac vessels, because 
the vascular phenotype in the yolk sac of nrp-1 null embryos was not the same as published for 
embryos that completely lack flow, such as the ncx1-/- embryos (Wakimoto et al., 2000), or 
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embryos that exhibit only oscillatory flow, such as the mlc2a-/- embryos that we have previously 
analyzed (Lucitti et al., 2007).  We therefore created embryos that completely lacked flow in 
order to compare the vasculature of wild-type “no flow” embryos with those of nrp-1 mutants.  
By placing wild-type and mutant embryos into the same no-flow mode, the comparison of the 
phenotypes reflects only the role of nrp-1 and not normal vs. abnormal or absent flow.  We 
created no flow embryos by snipping the inlet to the heart in 4 somite embryos (see Methods), a 
stage when the heart has started beating but erythroblast circulation has not initiated.  These 
embryos are then cultured for 24 hours using whole embryo roller culture.  The presence or 
absence of flow is evaluated after culture at a stage when circulation of erythroblasts is normally 
evident.  The vasculature is then stained using antibodies to PECAM-1 and the number of vessel 
branch points, vessel segment length and avascular spaces are quantitated.  
 
In wild-type embryos with normal flow, key aspects of vascular remodeling were apparent after 
culture, such as changes in branch angle and the formation of large vessels in the yolk sac.  These 
large, regularly branched vessels are separated by capillary regions (Fig. 3A).  As observed in 
freshly dissected embryos (Fig. 1F), cultured nrp-1 mutants fail to undergo remodeling and to 
create a hierarchical branching system (Fig. 3A).  Though the overall vascular coverage was not 
affected in nrp-1 mutants (n= 12 for wild-type, n=10 for mutant, data not shown), the yolk sac 
vessels showed decreased branching, increased segment length and large spaces separating 
vessels. The difference in vessel diameter between wild-type and mutant embryos was also 
apparent in sections (inlays, Figure 3A). 
 
Comparing embryos in the no flow environment, we found that wild-type and knockout embryos 
did not show the same vascular phenotype (Figure 3A).  In wild-type no flow embryos, large 
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vessels never formed and the entire vasculature remained reminiscent of the capillary regions of 
the yolk sac with blood flow.  Vessel branching was decreased (Fig. 3B), however no change in 
segment length or in the area of avascular spaces was present compared to embryos experiencing 
normal flow (Fig 3C, D).  Cultured no flow nrp-1-/- embryos also showed decreased branching 
(Fig. 3B), but, in addition showed increased segment length (Fig. 3C) and increased area of 
avascular spaces (Fig. 3D), similar to the vascular phenotype of nrp-1-/- embryos in normal flow 
conditions and in striking contrast to the phenotype of wild-type no-flow embryos.  Thus, all 
aspects of the nrp-1-/- yolk sac vessel phenotype develop in no-flow culture conditions, indicating 
that the phenotype is due to loss of Nrp-1 function. 
 
Blocking Nrp-1 Function Reproduces the nrp-1-/- Yolk Sac Vessel 
Phenotype 
Having determined that loss of Nrp-1 function, rather than disturbed blood flow, was responsible 
for the altered vascular geometry in the yolk sac of nrp-1-/- embryos, we reasoned that blocking 
Nrp-1 function in wild-type embryos should reproduce the vascular phenotype observed in nrp-1 
null mutants.  We used antibodies that specifically block either Sema3A or VEGF-A binding to 
Nrp-1 (Pan et al., 2007a).  Treated embryos were cultured for 24 hours, PECAM-1 stained (Fig. 
4A-D) and yolk sac vessel branching and avascular spaces were quantified (Fig. 4E- G).  To 
optimize protein delivery to the yolk sac, we first compared direct addition of protein to the 
medium of cultured embryos and intracardiac injection of protein solution, using VEGF120, which 
is expected to increase vessel coverage. We found that intracardiac injection was preferable since 
VEGF120 could not diffuse across the yolk sac when added directly to the medium (data not 
shown).  Injection of VEGF120 led to an increase in the vascular coverage (from 74.1% ± 1.1 to 
85.9% ± 1.1) such that most of the yolk sac stained positive for PECAM-1 (Fig. 4B).  Having 
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optimized protein delivery, we analyzed the effects of intracardiac injection of Nrp-1 blocking 
antibodies (Pan et al., 2007a).  Anti-Nrp-1A antibody blocks Sema3A binding and anti-Nrp-1B is 
specific for the VEGF binding domain of Nrp-1, though both prevent receptor dimerization with 
VEGFR-2.  Both antibodies were capable of decreasing vessel branching and increasing segment 
length (Fig. 4C-F).  Anti-Nrp-1A had no effect on the area of avascular regions, but anti-Nrp-1B 
was able to create large avascular regions similar to those seen in the nrp-1-/- embryos (Fig. 4C, 
D, G).  Injection of both antibodies together did not create a synergistic effect on branching, and 
effects on avascular spaces were similar to the ones seen with anti-Nrp-1B alone (Fig 4G).  
Attempts at blocking Nrp-1 function by injection of soluble Nrp-1, which should sequester Nrp-1 
ligands including VEGF165 (Gagnon et al., 2000), had no effect on yolk sac vasculature (Fig. 4E-
G).  Injection of the Nrp-1 ligand Sema3A, which had previously been shown to compete with 
VEGF165 for Nrp-1 binding (Miao et al., 1999), also had no significant effects (Fig 4E-G), 
consistent with recent data showing directly that Sema3A and VEGF do not compete for binding 
to Nrp-1 (Appleton et al., 2007), and that Sema3A mutant mice lack an observable vascular 
phenotype (Vieira et al., 2007).  Though no effects were observed in these injection experiments, 
it was not possible to assess whether larger quantities of protein could have elicited a response.  
The embryo and its network of blood vessels are small at this stage and limit how much protein 
solution can be injected into the embryo without causing injury.  However, inhibition of Nrp-1 
function with a blocking antibody to the VEGF binding domain in wild-type embryos could 
clearly reproduce the altered vascular geometry observed in nrp-1 knockout yolk sacs, confirming 
that this aspect of the phenotype was due to loss of Nrp-1 function and not to altered blood flow. 
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Replication, sprouting, regression and migration in nrp-1-/- vessels 
Nrp-1 has been implicated in sprouting (Gerhardt et al., 2004), migration (Pan et al., 2007b) and 
proliferation of endothelial cells (Soker et al., 1998).  We therefore investigated how endothelial 
cell behavior in the yolk sac was different between mutant and wild-type embryos. Endothelial 
cell replication was assessed at various developmental stages in wild-type and mutant embryo 
yolk sacs using phospho-histone H3 and PECAM-1 double-staining (Fig. 5A). No significant 
difference in the number of dividing endothelial cells was observed between the two groups at all 
stages investigated (n=3-4 embryos per group with five images per embryo). Replication of 
smooth muscle cells and of total cells in the yolk sac at E9.5 was also similar between nrp-1 
knockouts and wild type (not shown).  Taken together with the similar total vessel coverage 
observed in wild type and knockouts, these results indicate that endothelial replication is unlikely 
to account for the observed yolk sac vessel defects in nrp-1 knockouts.  The sprouting and 
regression of vessels was assessed by counting the number of PECAM-1 stained endothelial cells 
extending into avascular spaces of the yolk sac, such that they formed dead-ended vessels 
(unconnected extensions).  No differences were observed between the different groups and the 
presence or absence of flow did not affect this measure (Fig. 5B). 
 
Endothelial cell migration was assessed by focal injection of a lipophilic carbocyanine dye (DiI) 
using a picospritzer into a capillary region of the yolk sac (red arrow, Fig. 5D, E) followed by 
culture to allow marked cells to migrate.  Regions where the fluorescence is continuous from cell 
to cell indicate endothelial cells migrating away from the site of injections (Fig. 5F, G).  In wild-
type embryos, marked cells migrate but remain confined within proximity to the injection site 
(Fig. 5C, D, F, n= 23).  Nrp-1 knockout DiI positive cells migrate along the abnormally formed 
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yolk sac capillaries and are found at greater distances from the injection area than wild-type cells 
(Fig. 5C, E, G, n= 5). Quantification of the distance of cell migration confirmed that endothelial 
cells migrated further away from the injection site in nrp-1-/- compared to wild-type yolk sacs 
(Fig. 5C), indicating that they exhibit abnormal migration.   
 
Defective Arterial Differentiation in Nrp-1-/- Embryos is Not Flow 
Related 
Previous reports have indicated that arterial differentiation is defective in endothelial-specific 
nrp-1 knockouts (Mukouyama et al., 2005).  Though arterial identity is established before the 
onset of flow, the expression of arterial markers remains plastic and changes with the flow that 
endothelial cells are exposed to.  If an embryonic artery is ligated to create an environment where 
the vessels experience venous flow, expression of markers such as ephrinB2 will be 
downregulated and expression of venous markers will be upregulated (le Noble et al., 2004).  
Other groups have also shown that endothelial cells change their gene expression depending on 
the waveform of the flow that they are exposed to (Blackman et al., 2002).  We therefore 
investigated whether changes in arterial-venous gene expression in nrp-1 mutants were created by 
the abnormal flow present in these embryos.   
 
We examined the expression pattern of arterial markers Delta-like-4 (dll4), Connexin-40 (cx40) 
and Ephrin-B2 (efnb2) by in situ hybridization in both wild-type and mutant embryos (Fig. 6A-
F).  At E9.5, dll4 was expressed in the common atrial chamber of the heart and in the dorsal aorta 
of wild-type or heterozygous embryos (Fig. 6A).  In nrp-1-/- embryos (Fig. 6B), we observed 
expression both in the common atrial chamber and in the dorsal aorta (when present, red arrow 
denotes missing second dorsal aorta).  Cx40 expression can be seen specifically in the common 
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atrial chamber and in the dorsal aorta for wild-type embryos (Fig. 6C).  This expression is 
completely lacking in Nrp-1-/- embryos (Fig. 6D).  Efnb2 was expressed in the somites, neural 
tube, the dual dorsal aortae and the vitelline artery of wild-type (Fig. 6E). Nrp-1-/- embryos 
showed normal efnb2 expression in somites and neural tube, as well as staining in the 
endothelium of the dorsal aorta, but labeling of the vitelline artery was reduced compared to wild-
type or heterozygous littermates (Fig. 6F).   
 
To further explore differences in gene expression between nrp-1-/- and wild-type embryos, we 
used quantitative RT-PCR.  Endothelial cells were isolated from 2-3 embryos using Dynabeads 
coated with antibodies against PECAM-1 (see Methods).  From this cell population, RNA was 
extracted and analyzed.  To rule out effects of flow induced gene expression, we also tested 
endothelial cell gene expression in wild type and mutant embryos that lacked flow.  In all, 6 sets 
of 2 to 3 embryos were analyzed per group.  The relative expression levels were measured for 11 
cardiovascular genes (Fig. 6G); 4 pan-endothelial, 4 arterial and 3 venous. These were normalized 
to 3 housekeeping genes, β-actin, α-tubulin and gapdh.  Most genes showed no significant 
difference in expression level between wild-type, nrp-1-/-, no-flow wild-type and no-flow 
knockout (hif1α, vegfr2, ve-cadherin, dll4, nrp-2 and ephB4).  Expression of vegf-a and unc5b 
was altered in endothelial cells of nrp-1 mutants compared to wild type (Fig. 6G).  Stopping flow, 
however, eliminated the difference between wild-type and mutant indicating that no difference is 
seen when observed on the same flow background.  CouptfII levels were unaffected by the nrp-1 
mutation but were decreased in no-flow conditions (Fig. 6G).  In contrast to these genes, 
expression of the arterial markers efnb2 and cx40 was specifically down-regulated in nrp-1 
mutants (Fig. 6G), as reported previously in endothelial-specific nrp-1 knockouts (Mukouyama et 
al., 2005).  The decrease in efnb2 levels was modest, confirming the in situ hybridization results 
indicating that not all vessels lost efnb2 expression, while expression of cx40 was strongly 
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decreased in nrp-1 mutants.  Down-regulation of efnb2 and cx40 was not flow related but specific 
to loss of nrp-1, since the difference was present between no-flow wild type and knockout 
embryos as well. 
 
Discussion 
Vessel remodeling and flow defects in Nrp-1-/- mutants 
In this work, we study the role of Nrp-1 in cardiovascular development.  A previous study of nrp-
1-/- embryos showed that embryonic lethality occurred at E10.5 on a C57BL/6 background, but 
only at E13.5 on a CD-1 background (Kitsukawa et al., 1997).  Cardiovascular defects in nrp-1 
mutants were so far only analyzed in the CD-1 mutants (Kawasaki et al., 1999) and in 
endothelial-specific conditional mutants, which also die at E13.5 (Gerhardt et al., 2004; Gu et al., 
2003; Mukouyama et al., 2005).  In agreement with the initial report (Kitsukawa et al., 1997), our 
extensive analysis of an nrp-1 mutant allele bred on C57BL/6 showed lethality at E10.5.  In fact, 
these nrp-1-/- embryos show arrest of all cardiovascular progress one day after cardiovascular 
function normally begins.  The heart has looped but no trabeculations form. The dorsal aortae 
form normally at E8.5 but are regressing by E9.5, and smooth muscle cells do not surround large 
vessels.  Yolk sac vessels fail to remodel into arteries and veins, show reduced branching, 
diameter increase and enlarged avascular spaces.  The embryo begins to appear necrotic by E9.5 
and is slowly resorbed by E11.5.  Analysis of flow patterns showed that normal flow was never 
observed in nrp-1 null mutants.  As vascular defects appear concomitantly with blood flow 
defects, they could be secondary to the flow defects or caused by the nrp-1 mutation.  
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Though blood flow was aberrant in the nrp-1-/- embryos, no major cardiovascular defects were 
observed in the embryo proper when flow defects first became visible. Heart development and 
function were normal and all the major vessels of the embryo were present and lumenized at 
E8.5.  More subtle changes in heart function cannot be measured at these young stages and 
remain a possible cause of flow insufficiencies.  However, the defects in the yolk sac vasculature 
may actually cause the abnormal flow.  When the heart begins to contract at 3 somites, a period of 
plasma flow is initiated (Lucitti et al., 2007).  As heart development continues, plasma flow 
increases and eventually carries erythroblasts into circulation.  Enlarged yolk sac vessels would 
require a larger pump (or stronger heart) than normal to create an equivalent velocity of plasma 
flow in the vessels given the laws of conservation of mass.  If the plasma is not flowing fast 
enough, then the erythroblasts cannot circulate.  Nrp-1-/- embryos on a CD-1 background are not 
resorbed until E13.5 (Kitsukawa et al., 1997), although they show aberrant yolk sac vessel 
geometry similar to the one described here (Kawasaki et al., 1999).  We speculate that the 
difference in the stage at which the mutant embryos die in these two backgrounds could be due to 
slightly increased embryo growth rate, heart contractility and blood flow in CD-1 versus 
C57BL/6 embryos, which would be sufficient to initiate blood flow but still encounter altered 
vascular geometry and eventually fail to establish proper circulation.  
 
Separating genetic and flow defects in Nrp-1-/- mutants 
Abnormal flow makes analysis of mouse mutants challenging since it becomes a question of 
whether flow or loss of signaling function cause the mutant phenotype. In n-cadherin mutants, 
cardiac-specific rescue of gene expression was sufficient to rescue flow and cardiovascular 
defects observed in null mutants (Luo et al., 2001). As no obvious cardiac defects were detected 
in the nrp-1 null mutants, we did not attempt cardiac-specific re-expression of nrp-1.  To identify 
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aspects of the phenotype caused by loss of nrp-1 function, we sought to compare embryos in the 
same flow environment and decided to analyze embryos in the absence of flow.  We find that the 
geometry of the capillary plexus in nrp-1 null embryos in a no flow environment is altered such 
that there are fewer branch points, longer vessel segments and larger avascular spaces between 
vessels, indicative of increased vessel diameter.  This phenotype is seen in both no-flow and 
untreated nrp-1 null embryos and therefore not related to flow. This method allowed us to 
identify aspects of the phenotype that are purely due to loss of Nrp-1 function.  The relative 
simplicity of the method, as compared to transgenic rescue experiments, makes it easily 
applicable to analysis of numerous mouse mutants for genes involved in cardiovascular 
development in which abnormal flow is suspected. 
 
Formation of Defective Capillary Geometry in nrp-1-/- mutants 
To confirm that altered yolk sac vessel geometry in nrp-1-/- mutants was due to loss of Nrp-1 
function rather than to abnormal flow, we injected wild-type embryos with blocking antibodies 
specific to either the Sema3A or the VEGF binding domains of Nrp-1.  Both antibodies decreased 
yolk sac vessel branching, but only the Nrp-1B VEGF blocking antibody led to phenocopy of all 
aspects of the nrp1-/- vascular morphology.  Previous studies have shown that both antibodies 
reduce VEGF-driven endothelial cell migration and sprouting angiogenesis in various in vitro and 
in vivo models, with anti-Nrp-1B being slightly more potent than anti-Nrp-1A (Pan et al., 2007a).  
Both antibodies disrupt complex formation of Nrp-1 and VEGFR-2, suggesting that both inhibit 
VEGF-driven motility via disruption of complex formation and downstream signaling events.  
Our results agree with these findings, as inhibiting the Sema3A-binding domain showed a small 
effect on vascular morphology, while injection of antibodies that block the VEGF-binding 
domain mimicked multiple aspects of the nrp-1-/- phenotype.  Furthermore, injection of antibody 
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blocking VEGF binding to Nrp-1 could induce the nrp-1-/- capillary phenotype in wild-type 
embryos experiencing normal flow.  These experiments therefore clearly identify the aberrant 
vascular geometry as a primary defect due to loss of Nrp-1 signaling.  
 
Endothelial replication was similar between wild-type and mutants and could not account for the 
altered nrp-1-/- yolk sac vessel geometry.  Thus, loss of Nrp-1 function does not influence 
endothelial cell replication in vivo, confirming previous findings with antibodies blocking VEGF 
or Sema3A binding to Nrp-1, which failed to inhibit VEGF-driven endothelial proliferation in 
vitro (Pan et al., 2007a). We also found no differences in sprouting/regression between wild type 
and nrp-1-/- mutants.  However, the number of PECAM positive endothelial cells extending into 
avascular yolk sac areas was very low (less than 1 per mm2).  Time-lapse studies in early quail 
embryos have shown that formation of the vascular plexus involves endothelial cell migration 
along existing endothelial cord structures as well as sprouting (Rupp et al., 2003).  While 
sprouting appeared to be an important mechanism to generate new vascular cords, only a small 
fraction of endothelial cells was shown to exhibit protrusive behavior over the period of recording 
(Perryn et al., 2008).  Thus, sprout formation in yolk sac vessels may be missed in fixed samples.  
We can therefore not rule out altered sprouting or regression of yolk sac endothelial cells as a 
potential mechanism accounting for the altered vascular morphology of nrp-1 null yolk sacs. 
 
We found significant differences in the pattern of endothelial migration between wild-type and 
nrp-1-/- mutants.  Focal DiI injections showed that nrp-1 knockout cells are found at greater 
distances from the injection area than wild-type cells.  This observation was surprising, as one 
might have expected migration of nrp-1-/- cells to be decreased.  However, the mutant cells 
appeared to migrate along existing endothelial cell cords and were never seen leaving existing 
vessels.  Thus, rather than exhibiting a general block of migration, it appears that nrp-1 mutant 
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cells fail to migrate in the proper direction, most likely via loss of VEGF signaling.  Migration 
along existing capillaries has been shown to require cell-cell rather than extracellular matrix 
interactions (Rupp et al., 2003), suggesting that interactions between endothelial Nrp-1 and 
matrix-bound VEGF may be disrupted in the mutant mice.  Loss of Nrp-1 function may thus 
perturb binding of extracellular matrix-bound VEGF164, complex formation with VEGFR-2 and 
downstream signaling, leading to inhibition of directional migration and vessel branching, 
without affecting other aspects of endothelial function such as proliferation.  Such a mechanism 
would explain the reduction in branchpoints and larger vessel diameters since the same numbers 
of endothelial cells are creating fewer vessels.  Alternatively, as qPCR analysis has shown that 
nrp-1 mutant endothelial cells express elevated vegf mRNA levels, increases in VEGF signaling 
through VEGFR-2 may cause the increase in endothelial migration we observe.  We find this 
model unlikely, however, as vegf levels in cultured no-flow wild-type or nrp-1-/- mutants are 
similar, yet their vascular phenotypes differ.  Furthermore, injection of antibodies blocking VEGF 
binding to Nrp-1 into wild-type embryos with normal flow and presumably unaltered VEGF 
levels can reproduce altered capillary geometry.  
Endothelial Gene Regulation by Nrp-1 
As the maintenance of expression of arterial markers requires flow (le Noble et al., 2004), we 
investigated whether changes in arterial-venous gene expression in nrp-1 mutants were created by 
the abnormal flow present in these embryos. We found that expression levels of arterial markers 
cx40 and efnb2 were decreased in nrp-1 mutants compared to wild-type embryos.  For efnb2, this 
change appears to be linked to extra-embryonic vessels as highlighted by the loss of expression in 
the vitelline artery.  These two genes were previously reported downregulated in endothelial-
specific conditional Nrp-1 knockout embryos (Mukouyama et al., 2005), however the effect of 
flow was not analyzed.  Wild-type embryos cultured in no-flow conditions showed no changes in 
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the expression levels of these two genes, indicating that the decrease was specific for the nrp-1 
mutation and not secondary to altered blood flow, thus confirming and extending previous reports 
(Mukouyama et al., 2005).   
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Figure Legends 
 
Figure 1 – Cardiovascular Phenotype of nrp-1-/- Embryos. Dark field images of freshly 
dissected yolk sacs from E9.5 embryos with the indicated genotypes (A, E) shows defects in yolk 
sac vascular remodeling that are further highlighted by PECAM-1 staining of the wild-type (B) 
and mutant (F) yolk sacs.  Angiograms at E8.5, just after the onset of plasma flow, (C, G) show 
that vessels are lumenized in both wild-type (C) and knockout (G) embryos, but that Nrp-1-/- 
already show altered yolk sac vessel geometry (G).  PECAM-1 stainings of yolk sacs (D,H) were 
used to quantitate the phenotype based on the number of branchpoints per mm2 (I), average vessel 
segment length (J) and area of avascular spaces (K) at different stages of development for wild-
type and knockout embryos. * p<0.05, ** p <0.01, *** p<0.005 student’s two tailed t-test.  Scale 
bars; 1mm (A, E), 500 μm (B, C, F, G) 100 μm (D, H). 
 
Figure 2 – Investigating Causes of Defective Flow in Nrp-1-/- Embryos.  In situ hybridization 
with a nrp-1 antisense riboprobe on a section from a wild-type embryo at 10 somites (A) shows 
expression in the atrium (marked A) and not the ventricle (marked V), as well as expression in the 
dorsal aortae (arrows) and yolk sac vessels (arrowheads). Serial sections of E8.5 wild-type (B) 
and mutant (D) embryos stained for PECAM-1 show that dorsal aortae (marked DA) are present 
and lumenized in both cases, though often collapsed in the mutant (D).  By E9.5, Collagen IV 
staining highlights the dorsal aortae (DA), gut (G) and heart (H) of wild-type embryos (C).  In 
mutant embryos, one or both dorsal aortae are often missing (E, arrow).  Intersomitic vessel 
sprouting is visible in E9.5 wild-type embryos stained for PECAM-1 (F) but is delayed in mutant 
embryos (G) and also shows the collapsed dorsal aorta (arrow).  The cephalic region of E9.5 
wild-type embryos shows an extensive vasculature (H) that is also present in the mutant embryos 
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(I), however the vasculature of the mutants is more sparse and many vessels do not appear to be 
lumenized.  The internal carotid artery (ICA) has started forming in the wild-type (H) but is 
lacking in the mutant (I).  Scale bars; 50 μm (A, B, D), 100 μm (F, G, H, I), 200 μm (C, E). 
 
Figure 3 – Separating the Role of Blood Flow from Nrp-1 Function.  PECAM-1 staining of 
yolk sacs from cultured heterozygote and mutant embryos in both flow and no-flow conditions, as 
indicated (A).  In heterozygote embryos with flow, a large remodeled artery (Art) is visible. 
Heterozygote embryos without flow fail to remodel capillaries into large vessels.  Nrp-1-/- vessels, 
with or without flow, show decreased branching (B), increased vessel segment length (C) and 
increased avascular spaces (D).  Inlays in (A) show collagen IV staining on sections from E9.5 
yolk sacs that also highlight the large vessel diameters in nrp-1-/- yolk sacs compared to wild-type.  
** p<0.01, *** p<0.005 student’s two tailed t-test.  Scale bars; 100 μm. 
 
Figure 4 – Blocking Nrp-1 Function Reproduces the nrp-1-/- Yolk Sac Vessel Phenotype.  
Wild-type embryos from a CD-1 background were treated with various proteins by intracardiac 
injection followed by whole embryo culture.  Subsequent to culture, the vasculature was fixed 
and stained for PECAM-1 (A-D).  The images were quantified for vascular morphology (E-G).  
Untreated embryos showed remodeling, typical of E9.5 embryos (A).  VEGF120 injection caused 
an increase in overall vascular coverage (B).  Injection of antibodies against Nrp-1, which are 
reported to block Sema3A binding (C) and VEGF binding (D) to Nrp-1 respectively (Pan et al., 
2007b), were both effective at decreasing the number of branchpoints and increasing vessel 
segment length as seen in the Nrp-1-/- embryos (E, F).  Injection of both antibodies did not show a 
synergistic effect on the number of branchpoints.  Only antibodies against the VEGF binding 
domain of Nrp-1 were capable of increasing average area of avascular space, as seen in Nrp-1-/- 
embryos (G). Injection of Sem3A and sNrp-1 had no statistically significant effect on capillary 
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geometry (E-G).  * p<0.05, ** p<0.01, *** p<0.005, student two-tailed t-test.  Scale bars; 100 
μm. 
 
Figure 5 – Replication, Sprouting and Migration in nrp-1-/- yolk sacs.  Endothelial replication 
was quantitated using double staining with phospho-histone 3 and PECAM-1 at different stages 
of development (A).  No statistically significant difference was seen at any of the stages 
examined.  The number of PECAM-1 positive unconnected segments extending into avascular 
spaces, which may represent sprouts or regressing vessels, was assessed from images of the yolk 
sac at E9.5 (B).  No significant differences were observed between the different groups.  
Endothelial cell migration was assessed by focal injection of cell tracker CM-DiI into a capillary 
region (C-G) of the yolk sac followed by quantification of the maximum migration distance per 
embryo (C).  The initial injection site can be observed in the white light images (red arrows, D & 
E).  Endothelial cells did not migrate very far away from the site of injection in wild-type 
embryos (F) but were seen migrating longer distances along existing capillaries for knockout 
embryos (G). * p<0.05, student’s two tailed t-test.  Scale bar; 1mm. 
 
Figure 6 – Arterial Venous Gene Expression in nrp-1-/- Embryos.  A-F: Serial sections were 
stained by in situ hybridization for dll4 (A, B), cx40 (C, D), efnb2 (E, F) in both wild-type (A, C, 
E) and nrp-1 knockout embryos (B, D, F) at 20 somites.  Images show the common atrial 
chamber (CAC), the vitelline artery (VA) and the dorsal aortae (DA) at either the level of the 
heart (A-D) or at the caudal end of the embryo (E, F).  B: Red arrow denotes a missing dorsal 
aorta in the nrp-1-/- embryo, note that the remaining dorsal aorta still expresses dll4. D: Note 
absence of cx40 expression in nrp-1-/- embryos. F: Normal expression of efbn2 is present in dorsal 
aorta and somites of nrp-1-/- embryos, but lacking in the vitelline artery. G: Levels of gene 
expression were measured from isolated endothelial cells, either pooled wild-type/heterozygous 
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(denoted wild-type) or knockout, both with and without blood flow for 11 cardiovascular genes; 4 
pan-endothelial genes, 4 arterial genes and 3 venous genes. Gene expression was normalized to 
three housekeeping genes; α-tubulin, β-actin and gapdh. Note that expression of cx40 and efbn2 
in nrp-1-/- is downregulated compared to wild-type regardless of flow environment. * p<0.05, 
**p<0.01, ***p<0.005, student’s two-tailed t-test. Scale bars; 100 μm. 
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Supplementary Figure Legend 
 
Figure 1 – Illustration of morphometry used for quantifying vessel geometry in wild-type 
and nrp-1 homozygous mutant yolk sacs.  PECAM-1 stainings of wild-type (A) and knockout 
(C) yolk sacs were used to quantitate the vascular phenotype.   Images were first thresholded to 
create binary images (B,D). Total vessel area was assessed by counting the number of red vs 
black pixels in the binary images.  A vessel skeleton (blue lines) was extracted from the binary 
images using computer software (see Methods). Points where the skeleton lines intersect (white 
dots) are counted as branchpoints.  Segment length was assessed by dividing the total length of all 
skeleton lines by the number of intersections.  If the total vessel area is constant, and the number 
of vessel branchpoints is reduced, one expects that the length of individual vessel segments 
increases. Vessel diameter was assessed indirectly, by measuring the average area of an avascular 
space (hole) between vessels. With constant vessel area and increased space between vessels, it 
follows that the individual segments must be thicker. Scale bar; 100 μm. 
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Tables 
 
Table I – Blood Flow in Neuropilin Mutant Embryos 
 
Embryonic Stage  nrp1+/+ or nrp1+/-    nrp-1-/-   
 
E8.5 (10 somites)  100% Continuous Circulation   14% 
Continuous Circulation 
86% Oscillatory 
Circulation 
    (n=12)      (n=7) 
 
 
E9.5    100% Normal Circulation   100% Absence 
of Circulation 
    (n=13)      (n=4) 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Supplementary Figure 1 
 
 
 
